Programme
(preliminary)
* Attendees will have the opportunity to register individually on other days of the conference.
** Transport from Bratislava to Vienna is not organized; each participant is responsible for arranging their own transportation.
Session topics
- HESI workshop: Developing Consensus on the Use of Quantitative Dose-response Analysis for Risk Assessment of Mutagenic Substances
- NAMs: New Approach Methodologies
- NI session: New Investigators session
- EceToc: The European Centre for Ecotoxicology and Toxicology of Chemicals
- ICAWG: International Comet Assay Working Group
- Mutamind: Evaluation and Assessment of Mutagenicity of N-Nitrosamines Using In Vitro Tests
- ecNGS: Error-corrected New Generation Sequencing
- OECD TGs: OECD Test Guidelines
- Satellite workshop: Use of Genotoxicity Methods for Human Biomonitoring: Prevention – Diagnosis and Therapy of Cancer
Keynote speakers include a line-up of renowned experts in their respective fields
Prof. Silvia Pastoreková
(BMC SAS, Slovakia)
First Slovak EMBO member and a director general of BMC SAS
Presentation:
2.6.2025 – 18:00-19:00
Title: Molecular mechanisms of cancer cells’ adaptation to hypoxia and acidosis in tumor microenvironment
Dr. Helena Kanďárová
(CEM SAS, Slovakia)
President of The European Society of Toxicology In Vitro (ESTIV)
Presentation:
3.6.2025 – 14:00-15:00
Title: From Validation to Innovation: The Evolving Landscape of New Approach Methodologies in Regulatory Toxicology and Beyond
Prof. Jiří Neužil
(IBT CAS, Czechia & Griffith University, Australia)
Member of the Learned Society of the Czech Republic and Member of the International Committee for Mitochondrial Transfer and Transplantation Standardization
Presentation:
4.6.2025 – 14:00-15:00
Title: Horizontal Mitochondrial Transfer: A New Hallmark of Cancer with Clinical Relevance
Dr. Mária Dušinská
(NILU, Norway)
Awardee of EEMGS2024 Frits Sobels and Order of Ľudovít Štúr
Presentation:
5.6.2025 – 9:30-10:30
Title: Building Trust in Advanced Models: A Path to Standardization and Validation for Future Risk Assessment